Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D. Lehmann(Vanderbilt University Medical Center), X. Steven Chen(University of Miami)
Cited by 255
Related Papers
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
|Breast Cancer Research|2014|331
TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
|Cancer Informatics|2012|303